Tamiflu Clinical Trials Tamiflu RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and Chloroquin for Treatment of COVID19 : A Randomized Control Trial
Conditions:   Coronavirus Infections;   COVID19 Intervention:   Drug: Oral Sponsor:   Rajavithi Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2020 Category: Research Source Type: clinical trials